Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopeniaMarc Michel, Xuena Wang, Yoshiaki Tomiyama et al.|Annals of Hematology|2015Cited by 30